24O0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ReShape Lifesciences Inc

Watchlist Manager

Watchlist

Price: 4.93 EUR Market Closed

Market Cap: €17m

	ReShape Lifesciences Inc F:24O0	US
	Intrepid Capital Corp OTC:ITPC	US
A	Aquila Energy Efficiency Trust PLC LSE:AEEE	UK
P	Primary Health Properties PLC F:PP51	UK
	Standard Engineering Technology Ltd NSE:SETL	IN
T	TRX Gold Corp TSX:TRX	CA
N	Nickel Creek Platinum Corp OTC:NCPCF	CA
L	Life Electric Vehicles Holdings Inc OTC:LFEV	US
R	REGI U S Inc OTC:RGUS	US
	PacWest Equities Inc OTC:PWEI	US
	SinglePoint Inc OTC:SING	US
C	Chromadex Corp F:OCD1	US

Profitability Summary

ReShape Lifesciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

64%

Strong 3Y Average Gross Margin

64%

Gross Margin is Increasing

58% > 64%

Negative Operating Margin

-88%

Negative 3Y Average Operating Margin

-125%

Operating Margin is Increasing

-184% > -88%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-124%

Net Margin is Increasing

-334% > -48%

Negative Free Cash Flow Margin

-62%

Negative 3Y Average Free Cash Flow Margin

-120%

Free Cash Flow Margin is Increasing

-191% > -62%

Negative ROE

-120%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-210%

Declining ROIC

-114% > -186%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.